4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-067546
President and General Counsel sold 52,296 shares at an average $20.77 ($1,086,420)
- President and General Counsel acquired 52,296 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2018-11-08 | Option exercise | +5,300 | $11.79 | $62,487 | 204,805 | D |
| Shandell Jason B. President and General Counsel | 2018-11-08 | Option exercise | +30,901 | $10.46 | $323,224 | 235,706 | D |
| Shandell Jason B. President and General Counsel | 2018-11-08 | Sale | −36,201 | $20.68 | $748,586 | 199,505 | D |
| Shandell Jason B. President and General Counsel | 2018-11-09 | Option exercise | +16,095 | $10.46 | $168,354 | 215,600 | D |
| Shandell Jason B. President and General Counsel | 2018-11-09 | Sale | −16,095 | $20.99 | $337,834 | 199,505 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2018-11-08 | Option exercise · Employee Stock Option (right to buy) | −5,300 | 0 | D | ||
| Shandell Jason B. President and General Counsel | 2018-11-08 | Option exercise · Employee Stock Option (right to buy) | −30,901 | 16,095 | D | ||
| Shandell Jason B. President and General Counsel | 2018-11-09 | Option exercise · Employee Stock Option (right to buy) | −16,095 | 0 | D | ||
| Open-market sales · 52,296 sh · avg $20.77 · $1,086,420 | |||||||
Loading xslF345X03/a4.xml…